SinoCellTech (SHA: 688520) has received regulatory approval in China for finotonlimab, making it the first immuno-oncology ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

The World Health Organisation (WHO) is calling for cigarette-style warnings on alcohol to raise awareness about the link ...

The Andaman cobra is one of the rarest and least known of all cobra species. It is endemic to the Andaman and Little Andaman ...

Amgen will continue to advance half of the combo, PRMT5 inhibitor AMG 193, for which it is running a mid-stage trial in ...

Upon Opdualag’s approval in 2022 as a first-in-class cancer immunotherapy, Bristol Myers Squibb was anxious to explore its potential in a variety of indications. | Bristol Myers Squibb is striking out ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

Several important steps should be taken and/or considered after the identification of an oral cavity lesion: Perform a ...

The following is a summary of “Transcriptional regulatory network analysis identifies GRN as a key regulator bridging chemotherapy and immunotherapy response in small cell lung cancer,” published in ...

Scientists have discovered a new way to predict which cancer tumours will become aggressive before they spread – paving the way for treatments to stop the disease in its tracks.A new study, published ...